Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
Top Cited Papers
- 10 March 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 84 (10), 1017-1025
- https://doi.org/10.1212/wnl.0000000000001334
Abstract
Objective: To report long-term efficacy and safety results of the SANTE trial investigating deep brain stimulation of the anterior nucleus of the thalamus (ANT) for treatment of localization-related epilepsy. Methods: This long-term follow-up is a continuation of a previously reported trial of 5- vs 0-V ANT stimulation. Long-term follow-up began 13 months after device implantation with stimulation parameters adjusted at the investigators' discretion. Seizure frequency was determined using daily seizure diaries. Results: The median percent seizure reduction from baseline at 1 year was 41%, and 69% at 5 years. The responder rate (≥50% reduction in seizure frequency) at 1 year was 43%, and 68% at 5 years. In the 5 years of follow-up, 16% of subjects were seizure-free for at least 6 months. There were no reported unanticipated adverse device effects or symptomatic intracranial hemorrhages. The Liverpool Seizure Severity Scale and 31-item Quality of Life in Epilepsy measure showed statistically significant improvement over baseline by 1 year and at 5 years (p < 0.001). Conclusion: Long-term follow-up of ANT deep brain stimulation showed sustained efficacy and safety in a treatment-resistant population. Classification of evidence: This long-term follow-up provides Class IV evidence that for patients with drug-resistant partial epilepsy, anterior thalamic stimulation is associated with a 69% reduction in seizure frequency and a 34% serious device-related adverse event rate at 5 years.Keywords
This publication has 18 references indexed in Scilit:
- Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizuresEpilepsy & Behavior, 2012
- Therapeutic devices for epilepsyAnnals of Neurology, 2011
- Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsyEpilepsia, 2010
- Electrical Stimulation of the Anterior Nucleus of the Thalamus for Intractable Epilepsy: A Long‐term Follow‐up StudyEpilepsia, 2007
- Cognitive Decline in Severe Intractable EpilepsyEpilepsia, 2005
- Electrical Stimulation of the Anterior Nucleus of the Thalamus for the Treatment of Intractable EpilepsyEpilepsia, 2004
- The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy—a Canadian studySeizure, 2002
- Assessment of Seizure Severity with Adjunctive Lamotrigine Therapy: Results from a U.S. Observational StudyEpilepsy & Behavior, 2001
- Sudden Unexpected Death in EpilepsyJournal of Clinical Neurophysiology, 1991
- A permanent change in brain function resulting from daily electrical stimulationExperimental Neurology, 1969